Cell Therapy Tops Standard Care for Perianal Fistulas in Crohn's

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — PHOENIX — An implantable autologous cell therapy led to higher remission rates compared to standard surgical care in patients with persistent perianal Crohn’s fistulas who had failed previous treatments, the randomized phase…


:max_bytes(150000):strip_icc()/8560834728_2626216e21_k-9de0fa9704904904931d7424549ddb81.jpg?w=390&resize=390,220&ssl=1)